HIGHLIGHTS
- who: Wenwu He and collaborators from the Faculty of the Martin-LutherUniversity Halle-Wittenberg, Germany have published the Article: The efficacy and safety of neoadjuvant immunotherapy in resectable locally advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis, in the Journal: (JOURNAL)
- what: The authors aimed to obtain more accurate conclusions and summarize nICRT and nICT as reliable evidence for preoperative neoadjuvant therapy for locally advanced ESCC to facilitate clinical decisionmaking and the development of future randomized controlled phase 3 clinical trials. When p was and amp;lt;0.05 (for the Q . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.